Back to search

Article

Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya

2026-03-05

Abstract excerpt

<h4>Background</h4> In trials, three-month weekly rifapentine and isoniazid (3HP) showed higher adherence and completion than the six-month daily isoniazid (6H) regimen for TB preventive treatment (TPT). However, programmatic outcome data remain limited. <h4>Methodology</h4> We evaluated the TPT cascade among people with HIV (PWH) aged > 15 years newly enrolled in HIV care in western Kenya. Initiation and compl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6938551-1277-5f70-aa5f-693644e8f636
DOI
10.64898/2026.03.04.26347621
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western KenyaDOI 10.64898/2026.03.04.26347621
High initiation but sub-optimal completion of tuberculosis preventive treatment among people living with HIV on ART, persistent tuberculosis incidence and programmatic implications: Findings from a two-year multi-country cohort studySemantic proximity
Three months of weekly rifapentine and isoniazid versus four months of rifampicin for tuberculosis infection: a randomised controlled trialSemantic proximity
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in UgandaSemantic proximity
Empiric tuberculosis treatment and 12-month mortality among sputum GeneXpert-negative adults living with HIV in Uganda in the era of widespread Antiretroviral therapy: A prospective cohort studySemantic proximity
Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania: A qualitative study on acceptability of family approach in HIV care and treatment centersSemantic proximity
Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in UgandaSemantic proximity
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized unblinded trialSemantic proximity
Point-of-care HIV viral load and targeted drug resistance mutation testing versus standard care for Kenyan children on antiretroviral therapy (Opt4Kids): an open-label, randomised controlled trial.Semantic proximity
Implementation of a rapid diagnostic assay package for Cryptococcosis, Histoplasmosis and Tuberculosis in People Living with HIV in ParaguaySemantic proximity
Virologic outcomes and associated factors among people living with HIV on antiretroviral therapy in the Upper East Region of Ghana: a facility-based cross-sectional studySemantic proximity
Epidemiological characteristics of people living with HIV on antiretroviral therapy (ART) in Pointe-Noire, Republic of CongoSemantic proximity
Implementing a clinical pathway for diagnosing and treating acute HIV infection among key populations attending sexual health clinics in Indonesia: cohort profile of the INTERACT studySemantic proximity
Select a neighboring publication to make it the new centre.